Alerts & Corrections

AHFS Patient Medication Information Update – April 2016

The April update to the AHFS Patient Medication Information (PMI) database has been published. Highlights of this month’s update include:

New AHFS PMI Monographs

  • Buprenorphine Buccal (Belbuca®), indicated for severe chronic pain
  • Emtricitabine/Rilpivirine/Tenofovir (Complera®), indicated for HIV infection
  • Lesinurad (Zurampic®), indicated for hyperuricemia in people with gout
  • Posaconazole Injection (Noxafil®), indicated for prevention of fungal infections in people with weakened ability to fight infections

FDA MedWatch Alerts

  • New safety warnings for opioids
  • Risk of heart failure for alogliptin and saxagliptin
  • New safety warning for metformin in patients with reduced kidney function